Virtual Reality Therapy for Arm Recovery (VVITA) Stroke

NCT07103122 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-08-05

No results posted yet for this study

Summary

The study exploits new technologies appeared in the consumer electronics market to provide stroke patients with a low-cost, easy-to-use upper limb rehabilitation tool based on virtual reality. It aims to assess the potential, validity and participation in therapy while using virtual reality to improve limb rehabilitation through rehabilitation exercises that will use games chosen to improve the capabilities of the paretic upper limb. This therapy will be administered in addition to normal therapy and will be compared with a control group that will carry out the regular conventional therapy plus a neuromotor therapy dedicated to the upper limb of equal time and dose of interventional therapy.

Conditions

Interventions

OTHER

Experimental Group

A Personalized Adaptive Mirror Therapy for Upper-Limb Post-Stroke Rehabilitation using Virtual Reality and Myoelectric Control for 24 sesion in 8 weeks in add on to standard therapy.

OTHER

Control Group

Conventional Therapy

Sponsors & Collaborators

  • DLR German Aerospace Center

    collaborator OTHER
  • Friedrich-Alexander-Universität Erlangen-Nürnberg

    collaborator OTHER
  • University of Rome Tor Vergata

    collaborator OTHER
  • University of Roma La Sapienza

    collaborator OTHER
  • Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

    collaborator OTHER_GOV
  • IRCCS Centro Neurolesi Bonino Pulejo

    collaborator OTHER
  • University of L'Aquila

    collaborator OTHER
  • I.R.C.C.S. Fondazione Santa Lucia

    lead OTHER

Principal Investigators

  • Andrea d'Avella, PhD, Full Professor · 1) Laboratory of Neuromotor Physiology, IRCCS Fondazione Santa Lucia, Rome, Italy; 2)Department of Biology, University of Rome Tor Vergata, Rome, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-01
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07103122 on ClinicalTrials.gov